ad 20 has been researched along with Leukemia L 1210 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buc-Calderon, P; Praet, M; Roberfroid, M; Ruysschaert, JM | 2 |
| Allemon, AM; Buc Calderon, P; Roberfroid, M | 1 |
3 other study(ies) available for ad 20 and Leukemia L 1210
| Article | Year |
|---|---|
Reduction of toxicity and increase of antitumor effect of adriamycin by N-acyl dehydroalanines, a new family of free radical scavengers.
Topics: Alanine; Animals; Doxorubicin; Female; Free Radical Scavengers; In Vitro Techniques; Leukemia L1210; Leukemia, Experimental; Membrane Lipids; Mice; Mice, Inbred Strains; Microsomes, Liver; Oxidation-Reduction; Radiation-Protective Agents; Rats | 1990 |
Increasing therapeutic effect and reducing toxicity of doxorubicin by N-acyl dehydroalanines.
Topics: Alanine; Alanine Transaminase; Animals; Aspartate Aminotransferases; Bone Marrow; Doxorubicin; Leukemia L1210; Male; Mice | 1989 |
Potentiation of the therapeutic activity of cyclophosphamide by an original N-acyldehydroalanine.
Topics: Alanine; Animals; Cell Survival; Cyclophosphamide; Drug Synergism; Leukemia L1210; Male; Mice; Mice, Inbred DBA | 1987 |